News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • CNTB develops rademikibart to deliver rapid lung-function gains in acute asthma and COPD exacerbations.
  • CNTB market cap ~ $138.5M, shares trade near $2.20 after a $20.2M placement.
  • Company reports about $46M cash on the balance sheet.
  • Upcoming clinical readouts will determine whether rademikibart differentiates from Dupixent.
  • The setup is a binary, high-volatility swing trade; size positions accordingly.
  • Positive readouts could materially re-rate the stock, while negative results would likely cause sharp downside.

Latest Articles

Buy Agnico Eagle on the Dip: Tactical Long into Strength in Gold

Buy Agnico Eagle on the Dip: Tactical Long into Strength in Gold

Agnico Eagle (AEM) is a high-quality senior gold producer trading well below its 52-week high after a market-wide pullback. With a $89.8B market cap, reasonable multiples (P/E 16.6, P/B 3.36), dividend support and exposure to rising realized gold prices, AEM is a pragmatic long for long-term (180 trading days) traders willing to accept medium risk.…

Ingram Micro: Cheap Enough To Look Past Margin Noise

Ingram Micro: Cheap Enough To Look Past Margin Noise

Ingram Micro trades like a balance-sheet story more than a margin story. With a giant distribution footprint, recurring vendor contracts and a leaning toward higher-value services, the stock feels priced for a weak cycle. This trade idea buys that asymmetry: an entry at $45.00 with a $60.00 target and a $38.00 stop, horizon focused on capturing re-…

UNH Reversal: A High-Conviction Long After the Repricing

UNH Reversal: A High-Conviction Long After the Repricing

UnitedHealth has been marked down aggressively, but its core earnings engines - Medicare Advantage and Optum services - remain intact. This is a structured, medium-term trade idea targeting a comeback driven by margin recovery, benefit enrollment trends, and improving sentiment around managed care.

Virtuix to Host Fiscal Year 2026 Results Conference Call on Thursday, June 25, 2026, at 8:30 a.m. Eastern Time

Virtuix to Host Fiscal Year 2026 Results Conference Call on Thursday, June 25, 2026, at 8:30 a.m. Eastern Time

Virtuix Inc. (NASDAQ: VTIX), a leader in AI-driven full-body virtual reality systems, will hold a conference call on June 25, 2026, to discuss its fiscal year 2026 results. The company is reporting accelerating momentum in consumer, defense, and international markets, highlighting progress in AI-driven military simulation and strategic growth initi…

Greif, Inc. Declares 10.7% Increase to Quarterly Dividend

Greif, Inc. Declares 10.7% Increase to Quarterly Dividend

Greif, Inc., a global leader in industrial packaging, declared a 10.7% increase in its quarterly dividend for both Class A and Class B common stock, signaling strong free cash flow, improved balance sheet, and confidence in long-term earnings. The dividend increase aligns with the company's disciplined capital allocation strategy including maintain…

Cardiff Oncology Announces Presentation of Positive Results from its Randomized, Controlled Phase 2 Trial of Onvansertib in First-Line RAS-Mutated mCRC at the 2026 ASCO Annual Meeting

Cardiff Oncology Announces Presentation of Positive Results from its Randomized, Controlled Phase 2 Trial of Onvansertib in First-Line RAS-Mutated mCRC at the 2026 ASCO Annual Meeting

Cardiff Oncology announced positive results from its Phase 2 CRDF-004 trial evaluating onvansertib in combination with standard-of-care FOLFIRI/bevacizumab in first-line RAS-mutated metastatic colorectal cancer (mCRC). The 30 mg dose of onvansertib combined with FOLFIRI/bevacizumab showed a significant improvement in overall response rate (72.2% vs…

Myriad Genetics Names Raj Jampa as New Chief Technology Officer

Myriad Genetics Names Raj Jampa as New Chief Technology Officer

Myriad Genetics has appointed Raj Jampa as its new Chief Technology Officer effective June 1, 2026. Jampa brings significant experience in technology leadership and AI-enabled capabilities from prior roles at Agilent Technologies, Exact Sciences, and Genomic Health, positioning him to strengthen Myriad's digital technology foundation and support it…

Brookfield Renewable to Issue C$150 Million of  5.75% Preferred Units

Brookfield Renewable to Issue C$150 Million of 5.75% Preferred Units

Brookfield Renewable Partners L.P. announced a bought deal offering of 6 million Series 19 preferred units at C$25 each, raising C$150 million with a fixed 5.75% yield. The offering is aimed at funding eligible green investments and repaying related indebtedness, with an option to increase to C$200 million. The preferred units feature fixed quarter…

Virtu Financial Obtains MiCA License

Virtu Financial Obtains MiCA License

Virtu Financial announces that its subsidiary Virtu Financial Ireland Limited has obtained a MiCA license under the EU's Markets in Crypto-Assets Regulation, enabling the company to offer regulated digital asset services in all 27 EU member states. This milestone supports Virtu's expansion in the digital asset ecosystem, leveraging its market-makin…

UPDATE: Safe Pro Awarded U.S. Army Order For AI-Powered Threat Analysis Kit Together with Red Cat Black Widow Drones

UPDATE: Safe Pro Awarded U.S. Army Order For AI-Powered Threat Analysis Kit Together with Red Cat Black Widow Drones

Safe Pro Group Inc. announced it received a U.S. Army order for a Threat Analysis Kit integrating its AI-powered Navigation Observation & Detection Engine (NODE) with Red Cat Black Widow drones. The turnkey solution provides battlefield intelligence by rapidly processing drone video data to detect explosive threats and create detailed situational a…

Philips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti, delivering AI advancements in general imaging ultrasound

Philips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti, delivering AI advancements in general imaging ultrasound

Royal Philips announced FDA 510(k) clearance for Elevate Plus, an AI-powered software suite enhancing its flagship ultrasound systems EPIQ Elite and Affiniti. The technology automates key measurements, improves imaging quality, and integrates AI decision support to help clinicians perform faster, more consistent exams with reduced variability. Elev…

Oncolytics Biotech® Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer

Oncolytics Biotech® Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer

Oncolytics Biotech announced the appointment of Steve Glover to its Board of Directors and the promotion of John McAdory to Chief Operating Officer. Glover brings extensive public company leadership and acquisition experience, while McAdory will oversee clinical and preclinical development efforts. These leadership changes come as the company advan…

Strata Acquires Louisville Perfusion Services

Strata Acquires Louisville Perfusion Services

Strata Critical Medical, Inc. has completed the all-cash acquisition of Louisville Perfusion Services, a regional provider of perfusion and blood management services in Kentucky. This acquisition boosts Strata's presence in the Midwest and Southern U.S., strengthens its cardiac perfusion platform serving over 275 hospitals, and enhances support for…

Netskope Unveils AI Command Center, Delivering Comprehensive AI Discovery and Correlated Risk Intelligence with Fully Coordinated Agentic Response

Netskope Unveils AI Command Center, Delivering Comprehensive AI Discovery and Correlated Risk Intelligence with Fully Coordinated Agentic Response

Netskope announced the launch of its Netskope One AI Command Center, a platform designed to provide comprehensive AI asset discovery, unified risk intelligence, and autonomous agentic response. This new suite addresses rapid enterprise AI adoption challenges by improving visibility into AI usage and automating threat detection and response. It intr…